Status:
COMPLETED
Standard vs Mini-PCNL for the Treatment of Stone Disease
Lead Sponsor:
The Cleveland Clinic
Collaborating Sponsors:
University of British Columbia
Massachusetts General Hospital
Conditions:
Urolithiasis
Kidney Stone
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Randomized comparison of patient outcomes following standard PCNL versus mini-PCNL.
Detailed Description
This study is a randomized controlled trial which compares the operative outcomes and complications of mini-percutaneous nephrolithotomy (mini-PCNL) versus standard PCNL for renal stones. This study w...
Eligibility Criteria
Inclusion
- Patients planned for PCNL at participating institutions
- Age ≥ 18 years old
- Male and female patients
- Patients of all ethnic backgrounds
- Stone size 10-20mm
- Patients must be capable of giving informed consent and must be capable and willing to enroll and participate fully with the study.
Exclusion
- Conversion to open procedure
- Multiple access tracts
- Anticoagulated or history of coagulopathy
- Preoperative ureteral stent or nephrostomy tube placement
- Technical problems/impossibility of localizing the stone on the day of intervention
- Patients unable to give informed consent or unwilling to enroll or participate in the study will be excluded.
Key Trial Info
Start Date :
May 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 11 2025
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT04069013
Start Date
May 1 2022
End Date
November 11 2025
Last Update
January 7 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cleveland Clinic Foundation
Cleveland, Ohio, United States, 44195